Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-4-19
pubmed:abstractText
The eotaxin family comprises three distinct peptides (eotaxin, eotaxin-2 and eotaxin-3) which have been implicated in eosinophilic inflammation. In vitro and clinical studies suggest that eotaxins could play a role in vascular inflammation, but no data are available on their prognostic significance in patients with angiographically documented coronary artery disease (CAD).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0014-2972
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
211-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16620281-Aged, pubmed-meshheading:16620281-Biological Markers, pubmed-meshheading:16620281-C-Reactive Protein, pubmed-meshheading:16620281-Chemokine CCL11, pubmed-meshheading:16620281-Chemokine CCL24, pubmed-meshheading:16620281-Chemokines, CC, pubmed-meshheading:16620281-Confounding Factors (Epidemiology), pubmed-meshheading:16620281-Coronary Disease, pubmed-meshheading:16620281-Eosinophilia, pubmed-meshheading:16620281-Female, pubmed-meshheading:16620281-Follow-Up Studies, pubmed-meshheading:16620281-Humans, pubmed-meshheading:16620281-Male, pubmed-meshheading:16620281-Middle Aged, pubmed-meshheading:16620281-Myocardial Infarction, pubmed-meshheading:16620281-Prognosis, pubmed-meshheading:16620281-Proportional Hazards Models, pubmed-meshheading:16620281-ROC Curve, pubmed-meshheading:16620281-Risk Assessment
pubmed:year
2006
pubmed:articleTitle
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.
pubmed:affiliation
Department of Hematological, Pneumological and Cardiovascular Sciences, University of Pavia, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't